Ad is loading...
MDODX
Price
$10.34
Change
-$0.07 (-0.67%)
Updated
Nov 15 closing price
RNWHX
Price
$79.27
Change
-$0.78 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

MDODX vs RNWHX

Header iconMDODX vs RNWHX Comparison
Open Charts MDODX vs RNWHXBanner chart's image
Morgan Stanley Developing Opportunity R6
Price$10.34
Change-$0.07 (-0.67%)
VolumeN/A
CapitalizationN/A
American Funds New World R5E
Price$79.27
Change-$0.78 (-0.97%)
VolumeN/A
CapitalizationN/A
MDODX vs RNWHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDODX vs. RNWHX commentary
Nov 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDODX is a StrongBuy and RNWHX is a Hold.

FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 60.9B vs. MDODX (34M). RNWHX pays higher dividends than MDODX: RNWHX (1.44) vs MDODX (0.00). MDODX was incepted earlier than RNWHX: MDODX (5 years) vs RNWHX (9 years). RNWHX is a more actively managed with annual turnover of: 32.00 vs. MDODX (15.00). RNWHX has a lower initial minimum investment than MDODX: RNWHX (250) vs MDODX (5000000). MDODX annual gain was more profitable for investors over the last year : 23.83 vs. RNWHX (11.41).
MDODXRNWHXMDODX / RNWHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years9 years-
Gain YTD19.2627.006275%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets34M60.9B0%
Annual Yield % from dividends0.001.44-
Returns for 1 year23.8311.41209%
Returns for 3 years-21.19-14.83143%
Returns for 5 yearsN/A16.60-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDCM11.610.61
+5.55%
Radcom Ltd
CBL27.26-0.03
-0.11%
CBL & Associates Properties
FLEX37.20-0.44
-1.17%
Flex Ltd
CPOP1.19-0.08
-6.30%
Pop Culture Group Co Ltd
DYN28.39-1.92
-6.33%
Dyne Therapeutics